• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10621
Device Problems Material Rupture (1546); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/25/2023
Event Type  malfunction  
Event Description
It was reported that balloon rupture occurred.The 85% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 2.50 x 28 synergy drug-eluting stent was advanced for treatment.However, it was noted that the stent balloon burst.The procedure was completed successfully with another of the same device.There were no patient complications or injuries reported and patient condition is stable.
 
Manufacturer Narrative
E1: initial reporter facility name: (b)(6) hospital.E1: initial reporter phone number: (b)(6).
 
Manufacturer Narrative
Updated: e6: device code from material rupture to material deformation.E1: initial reporter facility name: (b)(6).E1: initial reporter phone number: (b)(6).
 
Event Description
It was reported that balloon rupture occurred.The 85% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 2.50 x 28 synergy drug-eluting stent was advanced for treatment.However, it was noted that the stent balloon burst.The procedure was completed successfully with another of the same device.There were no patient complications or injuries reported and patient condition is stable.It was further reported that the stent was lifted up, not a balloon ruptured as what previously reported and the device was removed intact.
 
Event Description
It was reported that balloon rupture occurred.The 85% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 2.50 x 28 synergy drug-eluting stent was advanced for treatment.However, it was noted that the stent balloon burst.The procedure was completed successfully with another of the same device.There were no patient complications or injuries reported and patient condition is stable.It was further reported that the stent was lifted up, not a balloon ruptured as what previously reported and the device was removed intact.
 
Manufacturer Narrative
Device evaluated by mfr.: synergy ous mr 2.50 x 28mm stent delivery system was returned for analysis.Visual and tactile inspection identified no issues with the hypotube shaft.No issues identified with the outer / mid-shaft sections or the inner lumen of the device.Microscopic examination identified no sign of damage, stretching or lifting of the stent struts.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.No signs of movement, stent was set between the proximal and distal markerbands.Bumper tip showed no signs of distal tip damage.The crimped stent outer diameter was measured and the result was within max crimped stent profile measurement.No device issues were identified during returned product analysis.(b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18580309
MDR Text Key334663641
Report Number2124215-2024-02647
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10621
Device Catalogue Number10621
Device Lot Number0030537863
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-